Cited by — Multitarget Therapy With Rituximab Plus Mycophenolate Mofetil Versus Rituximab Monotherapy in Systemic Sclerosis–Associated Interstitial Lung Disease | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Multitarget Therapy With Rituximab Plus Mycophenolate Mofetil Versus Rituximab Monotherapy in Systemic Sclerosis–Associated Interstitial Lung Disease.
No admitted local citation edges point to this work yet.
